Patients with T2D and overweight/obesity starting GLP-1 therapy may experience a small but statistically significant increase ...

Among patients without type 2 diabetes, GLP-1 drug use before weight-loss surgery increased to 23% in the fourth quarter of ...

Unusual side effects of GLP-1 drugs -- such as sagging jowls and deflated breasts -- are becoming more common, researchers ...

Alive News Investigates found a surprising number of people are getting their GLP-1 doses wrong, leading to an increase in ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

New research reveals that elevated GLP-1 and its receptor contribute to brain inflammation and nausea in NMOSD, offering a ...

The recent protein hubbub is teetering on overblown—not every snack food needs to be jacked up with the stuff. But there is one group of people who should pay extra attention to protein: those who ...

The growing use of GLP-1 drugs such as Wegovy and Ozempic is reducing Americans’ sugar consumption—users spend 6% less on ...

MARSHFIELD, Wis. (WSAW) - A Marshfield woman who nearly lost her life in an ATV accident has transformed her health and self-confidence by losing 93 pounds with GLP-1 medications. Shelly Messick’s ...

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April. The 25- year-old who lives in New York ...

GLP-1 RA use was associated with improved cardiometabolic outcomes among pediatric patients with type 2 diabetes and obesity.

Metabolic surgery was associated with lower mortality, major adverse cardiovascular events, nephropathy, and retinopathy than GLP-1 RAs.